JP2012519681A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012519681A5 JP2012519681A5 JP2011552537A JP2011552537A JP2012519681A5 JP 2012519681 A5 JP2012519681 A5 JP 2012519681A5 JP 2011552537 A JP2011552537 A JP 2011552537A JP 2011552537 A JP2011552537 A JP 2011552537A JP 2012519681 A5 JP2012519681 A5 JP 2012519681A5
- Authority
- JP
- Japan
- Prior art keywords
- leukocytes
- composition
- cells
- wound
- ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20929809P | 2009-03-05 | 2009-03-05 | |
| US61/209,298 | 2009-03-05 | ||
| US21158709P | 2009-04-01 | 2009-04-01 | |
| US61/211,587 | 2009-04-01 | ||
| PCT/IB2010/000882 WO2010100570A2 (en) | 2009-03-05 | 2010-03-05 | Activated leukocyte composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015046833A Division JP2015129180A (ja) | 2009-03-05 | 2015-03-10 | 活性化白血球組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012519681A JP2012519681A (ja) | 2012-08-30 |
| JP2012519681A5 true JP2012519681A5 (enExample) | 2013-03-28 |
| JP5713924B2 JP5713924B2 (ja) | 2015-05-07 |
Family
ID=42710060
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011552537A Expired - Fee Related JP5713924B2 (ja) | 2009-03-05 | 2010-03-05 | 活性化白血球組成物 |
| JP2015046833A Pending JP2015129180A (ja) | 2009-03-05 | 2015-03-10 | 活性化白血球組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015046833A Pending JP2015129180A (ja) | 2009-03-05 | 2015-03-10 | 活性化白血球組成物 |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP2403509B1 (enExample) |
| JP (2) | JP5713924B2 (enExample) |
| KR (1) | KR101548783B1 (enExample) |
| CN (1) | CN102438635B (enExample) |
| AU (1) | AU2010220132B2 (enExample) |
| BR (1) | BRPI1006759A2 (enExample) |
| CA (2) | CA2754190A1 (enExample) |
| DK (1) | DK2403509T3 (enExample) |
| ES (1) | ES2428102T3 (enExample) |
| IL (1) | IL214953A0 (enExample) |
| MX (1) | MX2011009277A (enExample) |
| PL (1) | PL2403509T3 (enExample) |
| RU (2) | RU2548741C2 (enExample) |
| WO (1) | WO2010100570A2 (enExample) |
| ZA (1) | ZA201107269B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8574902B2 (en) | 2009-03-05 | 2013-11-05 | Macrocure Ltd. | Activated leukocyte composition and uses for wound healing |
| BR112013005610A2 (pt) * | 2010-09-09 | 2019-09-24 | Macrocure Ltd | sobrenadante condicionado de leucócito, alcs, método para o tratamento de uma ferida, método para a inibição do surgimento de infecção em uma ferida, método, sobrenadante e produto |
| US20150030635A1 (en) | 2012-03-15 | 2015-01-29 | Macrocure, Ltd. | Activated Immunostimulatory Cell Composition and Uses Thereof |
| MX2014010893A (es) | 2012-03-15 | 2015-06-23 | Macrocure Ltd | Composicion celular inmunoestimulante activada para terapia de infecciones. |
| EP2781224A1 (en) * | 2013-03-18 | 2014-09-24 | Khorionyx | Implantable preparations comrpsing globin insoluble at physiological pH and serum for regeneration of tissues and treatment of wounds. |
| EP3258945B1 (en) | 2015-02-16 | 2020-10-07 | Nayacure Therapeutics Ltd. | Modified blood clots |
| GB201618106D0 (en) | 2016-10-26 | 2016-12-07 | Lift Biosciences Ltd | Cancer-killing cells |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60120821A (ja) * | 1983-12-05 | 1985-06-28 | Asahi Chem Ind Co Ltd | 悪性腫瘍治療用白血球刺激材および刺激方法 |
| US4751001A (en) * | 1984-09-24 | 1988-06-14 | Becton Dickinson And Company | Blood partitioning apparatus |
| JPH02167071A (ja) * | 1988-12-19 | 1990-06-27 | Terumo Corp | 非ヒト動物由来白血球系細胞の分離材、分離器および分離方法 |
| JPH07102151B2 (ja) * | 1994-06-03 | 1995-11-08 | 中外製薬株式会社 | 新規なポリペプチドの製造法 |
| IL110195A (en) * | 1994-07-03 | 2003-10-31 | David Danon | Method and system for cultivating macrophages |
| US6146890A (en) | 1994-07-03 | 2000-11-14 | Danon; David | Method and system for cultivating macrophages |
| US5837233A (en) * | 1995-03-17 | 1998-11-17 | University Of California | Method for treating tumors |
| JPH10259134A (ja) * | 1997-01-16 | 1998-09-29 | Sekisui Chem Co Ltd | 創傷治癒促進剤 |
| RU2143685C1 (ru) * | 1998-05-19 | 1999-12-27 | Коган Александр Харитонович | Способ дифференциального подсчета гранулоцитов, моноцитов и лимфоцитов |
| CN1335757A (zh) * | 1998-11-12 | 2002-02-13 | 聚合体生物科学公司 | 可用于快速凝血和止血的止血聚合物 |
| KR20100087781A (ko) * | 2001-11-21 | 2010-08-05 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 인간 단핵 식세포성 백혈구의 제조 방법 |
| JP4108393B2 (ja) * | 2002-07-15 | 2008-06-25 | テルモ株式会社 | 細胞増殖剤の製造方法 |
| JP4245324B2 (ja) * | 2002-10-09 | 2009-03-25 | 旭化成クラレメディカル株式会社 | 単球の分離回収方法 |
| EP2201954A1 (en) * | 2008-12-18 | 2010-06-30 | Aposcience AG | Pharmaceutical preparation |
| EP2198873A1 (en) * | 2008-12-18 | 2010-06-23 | Aposcience AG | Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture |
-
2010
- 2010-03-05 CN CN201080020134.XA patent/CN102438635B/zh not_active Expired - Fee Related
- 2010-03-05 WO PCT/IB2010/000882 patent/WO2010100570A2/en not_active Ceased
- 2010-03-05 CA CA2754190A patent/CA2754190A1/en not_active Abandoned
- 2010-03-05 CA CA2867976A patent/CA2867976A1/en not_active Abandoned
- 2010-03-05 JP JP2011552537A patent/JP5713924B2/ja not_active Expired - Fee Related
- 2010-03-05 PL PL10723285T patent/PL2403509T3/pl unknown
- 2010-03-05 EP EP10723285.2A patent/EP2403509B1/en not_active Not-in-force
- 2010-03-05 RU RU2011139016/15A patent/RU2548741C2/ru not_active IP Right Cessation
- 2010-03-05 BR BRPI1006759A patent/BRPI1006759A2/pt not_active IP Right Cessation
- 2010-03-05 MX MX2011009277A patent/MX2011009277A/es active IP Right Grant
- 2010-03-05 EP EP13176068.8A patent/EP2650001B1/en not_active Not-in-force
- 2010-03-05 DK DK10723285.2T patent/DK2403509T3/da active
- 2010-03-05 ES ES10723285T patent/ES2428102T3/es active Active
- 2010-03-05 RU RU2015102067/15A patent/RU2015102067A/ru not_active Application Discontinuation
- 2010-03-05 KR KR1020117023251A patent/KR101548783B1/ko not_active Expired - Fee Related
- 2010-03-05 AU AU2010220132A patent/AU2010220132B2/en not_active Ceased
-
2011
- 2011-09-04 IL IL214953A patent/IL214953A0/en unknown
- 2011-10-05 ZA ZA2011/07269A patent/ZA201107269B/en unknown
-
2015
- 2015-03-10 JP JP2015046833A patent/JP2015129180A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012519681A5 (enExample) | ||
| RU2707254C1 (ru) | Водный фармацевтический препарат и способ лечения хронической язвы | |
| GB2462228A (en) | Providing hemostasis in anticoagulated blood by using zeolites | |
| JP2013541010A5 (enExample) | ||
| RU2017121191A (ru) | Методика размножения гамма-дельта Т-клеток | |
| RU2011139016A (ru) | Активированная лейкоцитарная композиция | |
| JP2013528230A (ja) | ノーオプション重症虚血肢（ｃｌｉ）を処置するための組成物および方法 | |
| Roquilly et al. | Toll-like receptor-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells | |
| Razavi et al. | Application of novel strategies in chronic wound management with focusing on pressure ulcers: new perspective | |
| JP2013507945A5 (enExample) | ||
| Hajam et al. | The expanding impact of T-regs in the skin | |
| AU2013316718A1 (en) | Improved wound healing compositions comprising microspheres | |
| RU2512681C2 (ru) | Способ лечения длительно незаживающей раны и/или раневой полости | |
| Choi et al. | Harnessing the versatility of invariant NKT cells in a stepwise approach to sepsis immunotherapy | |
| Vancheri et al. | Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells | |
| WO2017060821A1 (en) | Hemostatic composition | |
| RU100724U1 (ru) | Атравматическое перевязочное средство с наночастицами серебра "асептика" | |
| Yawalkar | Maculopapular drug eruptions | |
| Uke et al. | The ideal donor site dressing: a comparison of a chitosan-based gelling dressing to traditional dressings | |
| Gormley et al. | The effect of methylprednisolone on cytokine concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system | |
| EP3585422A1 (en) | Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use | |
| BR102013031043A2 (pt) | Uso de compostos químicos capazes de inibir a ação tóxica das esfingomielinases d do veneno de aranhas loxosceles e composição farmacêutica compreendendo os referidos compostos | |
| JP2015140334A (ja) | 組織修復性マクロファージへの分化誘導剤および組織修復性マクロファージの製造方法 | |
| Cao et al. | Freestanding membranes of hydrogen-bonded organic frameworks for efficient wound healing | |
| Martires et al. | Graft-versus-host disease |